Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multifactor analysis of remimazolam induction dose for general anesthesia
ChiCTR2400085666Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Shandong Second Medical University
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam (3 arms), sponsored by Affiliated Hospital of Shandong Second Medical University. Primary endpoints: Remimazolam dosage, Hemoglobin and 3 more. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2400085666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085666.